Pfizer Inc.

Pfizer to allow generic versions of its antiviral COVID-19 pill in 95 countries

Health Canada could authorize Pfizer COVID-19 vaccine for kids 5-11 in ‘one to two weeks’

Health Canada approves Pfizer-BioNTech COVID-19 booster vaccine for adults

One year from Pfizer vaccine news, some unlikely market outcomes

French health authority advises against giving Moderna’s COVID-19 vaccine to people under 30

Merck ahead of Pfizer in EU talks on COVID-19 pills

Pfizer says its experimental antiviral pill for COVID-19 cuts risk of hospitalization, death by 89%

Health Canada backtracks on claim children’s COVID-19 vaccine approval will take months

COVID-19 vaccine recommended for children ages 5 to 11 by U.S. CDC

Pfizer expects at least $65-billion in sales from its COVID-19 vaccine in 2021, 2022

Coronavirus Update: U.S. could start vaccinating kids under 12 this week

COVID-19 vaccine for younger kids already being packed, shipped

FDA approves kids’ COVID-19 vaccine in U.S., Canada likely close behind

Pfizer Inc. takeover of cancer-drug developer Trillium Therapeutics approved by shareholders

Coronavirus Update: U.S. moves closer to approving vaccines for kids aged 5-11

FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids

COVID-19 vaccines for U.S. children aged 5-11 likely available in November, says Fauci

Pfizer COVID-19 vaccine shows 90.7% efficacy in clinical trial involving children